45 min
Moderna and CRISPR Therapeutics on fighting Covid-19 The Bid
-
- Investing
The Covid-19 pandemic has put genomics and immunology front and center. On the first episode of a five-part mini-series on megatrends, CEO of Moderna Stéphane Bancel and CEO of CRISPR Therapeutics Dr. Samarth Kulkarni share their perspectives as companies on the frontlines. First, Stéphane shares how Moderna innovated to produce a Covid-19 vaccine in record time and the potential of mRNA technology. Then, Samarth discusses how the medical breakthroughs of CRISPR technology will impact other medical crises like cancer and sickle cell disease in years to come.
The Covid-19 pandemic has put genomics and immunology front and center. On the first episode of a five-part mini-series on megatrends, CEO of Moderna Stéphane Bancel and CEO of CRISPR Therapeutics Dr. Samarth Kulkarni share their perspectives as companies on the frontlines. First, Stéphane shares how Moderna innovated to produce a Covid-19 vaccine in record time and the potential of mRNA technology. Then, Samarth discusses how the medical breakthroughs of CRISPR technology will impact other medical crises like cancer and sickle cell disease in years to come.
45 min